Website
Botanix Pharmaceuticals LimitedTelephone
61.8.62850083
Address
Suite 3 41–47 Colin Street West Perth, Western Australia (WA) 6005
Description
Botanix Pharmaceuticals Ltd. is a dermatology company, which engages in the provision of business of researching and developing dermatology and antimicrobial products. It operates through the Australia and the United States geographical segments. The company was founded by Matthew Callahan, Roger New, and Glen Travers in 1984 and is headquartered in West Perth, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.14 - 0.44
Trade Value (12mth)
AU$415,511.00
1 week
8.45%
1 month
20.31%
YTD
102.63%
1 year
165.52%
All time high
163.33
EPS 3 yr Growth
170.60%
EBITDA Margin
%
Operating Cashflow
-$8m
Free Cash Flow Return
-12.30%
ROIC
-21.10%
Interest Coverage
-1,443.60
Quick Ratio
21.90
Shares on Issue (Fully Dilluted)
1810m
HALO Sector
Healthcare
Next Company Report Date
28-Aug-25
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.01
Date | Announcements |
---|---|
03 December 24 |
Change of Director's Interest Notice x 5
×
Change of Director's Interest Notice x 5 |
02 December 24 |
Application for quotation of securities - BOT
×
Application for quotation of securities - BOT |
02 December 24 |
Notification regarding unquoted securities - BOT
×
Notification regarding unquoted securities - BOT |
02 December 24 |
Section 708A(5)(e) Notice
×
Section 708A(5)(e) Notice |
19 November 24 |
Botanix Presentation at Bell Potter Healthcare Conference
×
Botanix Presentation at Bell Potter Healthcare Conference |
14 November 24 |
Botanix Adds to Payer Coverage
×
Botanix Adds to Payer Coverage |
04 November 24 |
Annual General Meeting - Chairman's Address
×
Annual General Meeting - Chairman's Address |
04 November 24 |
Annual General Meeting - Presentation
×
Annual General Meeting - Presentation |
04 November 24 |
Results of Annual General Meeting
×
Results of Annual General Meeting |
28 October 24 |
September 2024 Quarterly Activities Report and Appendix 4C
×
September 2024 Quarterly Activities Report and Appendix 4C |
08 October 24 |
Application for quotation of securities - BOT
×
Application for quotation of securities - BOT |
08 October 24 |
Notification of cessation of securities - BOT
×
Notification of cessation of securities - BOT |
08 October 24 |
Section 708A(5)(e) Notice
×
Section 708A(5)(e) Notice |
03 October 24 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
03 October 24 |
Letter to Shareholders - Notice of Annual General Meeting
×
Letter to Shareholders - Notice of Annual General Meeting |
03 October 24 |
Botanix Staff Update and AGM Notice of Meeting
×
Botanix Staff Update and AGM Notice of Meeting |
24 September 24 |
Botanix Investor Presentations and Roadshow
×
Botanix Investor Presentations and Roadshow |
19 September 24 |
Annual Report
×
Annual Report |
19 September 24 |
Appendix 4G and Corporate Governance Statement
×
Appendix 4G and Corporate Governance Statement |
16 September 24 |
Botanix Webinar - Presentation Copy
×
Botanix Webinar - Presentation Copy |
11 September 24 |
Botanix Commercial Day Webinar - Registration Information
×
Botanix Commercial Day Webinar - Registration Information |
10 September 24 |
2024 Annual General Meeting - Key Dates
×
2024 Annual General Meeting - Key Dates |
04 September 24 |
Notification of cessation of securities - BOT
×
Notification of cessation of securities - BOT |
04 September 24 |
Application for quotation of securities - BOT
×
Application for quotation of securities - BOT |
04 September 24 |
Section 708A(5)(e) Notice
×
Section 708A(5)(e) Notice |
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Historical data
Forecast data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.